nodes	percent_of_prediction	percent_of_DWPC	metapath
Pilocarpine—CYP2E1—Dacarbazine—melanoma	0.227	0.444	CbGbCtD
Pilocarpine—CYP3A4—Temozolomide—melanoma	0.164	0.32	CbGbCtD
Pilocarpine—CYP3A4—Vemurafenib—melanoma	0.0898	0.175	CbGbCtD
Pilocarpine—CYP3A4—Docetaxel—melanoma	0.0308	0.0602	CbGbCtD
Pilocarpine—Pneumonia—Dactinomycin—melanoma	0.0012	0.0032	CcSEcCtD
Pilocarpine—Oesophagitis—Docetaxel—melanoma	0.00118	0.00313	CcSEcCtD
Pilocarpine—Decreased appetite—Vemurafenib—melanoma	0.00118	0.00312	CcSEcCtD
Pilocarpine—Bronchitis—Temozolomide—melanoma	0.00117	0.00311	CcSEcCtD
Pilocarpine—Stomatitis—Dactinomycin—melanoma	0.00117	0.0031	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Vemurafenib—melanoma	0.00117	0.0031	CcSEcCtD
Pilocarpine—Constipation—Vemurafenib—melanoma	0.00116	0.00307	CcSEcCtD
Pilocarpine—Hypoaesthesia—Bleomycin—melanoma	0.00115	0.00305	CcSEcCtD
Pilocarpine—Pulmonary oedema—Docetaxel—melanoma	0.00115	0.00305	CcSEcCtD
Pilocarpine—Dysuria—Temozolomide—melanoma	0.00114	0.00302	CcSEcCtD
Pilocarpine—Pneumonia—Carmustine—melanoma	0.00113	0.003	CcSEcCtD
Pilocarpine—Pollakiuria—Temozolomide—melanoma	0.00112	0.00298	CcSEcCtD
Pilocarpine—Photosensitivity reaction—Temozolomide—melanoma	0.00111	0.00295	CcSEcCtD
Pilocarpine—Stomatitis—Carmustine—melanoma	0.00109	0.0029	CcSEcCtD
Pilocarpine—Urinary tract infection—Carmustine—melanoma	0.00109	0.0029	CcSEcCtD
Pilocarpine—Pneumonia—Temozolomide—melanoma	0.00109	0.0029	CcSEcCtD
Pilocarpine—Hepatitis—Dactinomycin—melanoma	0.00108	0.00286	CcSEcCtD
Pilocarpine—Flushing—Bleomycin—melanoma	0.00107	0.00284	CcSEcCtD
Pilocarpine—Body temperature increased—Vemurafenib—melanoma	0.00107	0.00284	CcSEcCtD
Pilocarpine—Pharyngitis—Dactinomycin—melanoma	0.00107	0.00284	CcSEcCtD
Pilocarpine—Stomatitis—Temozolomide—melanoma	0.00106	0.00281	CcSEcCtD
Pilocarpine—Urinary tract infection—Temozolomide—melanoma	0.00105	0.0028	CcSEcCtD
Pilocarpine—Deafness—Docetaxel—melanoma	0.00105	0.00278	CcSEcCtD
Pilocarpine—Chills—Bleomycin—melanoma	0.00103	0.00275	CcSEcCtD
Pilocarpine—Alopecia—Bleomycin—melanoma	0.00102	0.00271	CcSEcCtD
Pilocarpine—Sinusitis—Temozolomide—melanoma	0.00102	0.0027	CcSEcCtD
Pilocarpine—Hypoaesthesia—Carmustine—melanoma	0.001	0.00266	CcSEcCtD
Pilocarpine—Flushing—Dactinomycin—melanoma	0.000998	0.00265	CcSEcCtD
Pilocarpine—Hypersensitivity—Vemurafenib—melanoma	0.000996	0.00265	CcSEcCtD
Pilocarpine—Oedema peripheral—Carmustine—melanoma	0.000992	0.00264	CcSEcCtD
Pilocarpine—Dermatitis bullous—Docetaxel—melanoma	0.000978	0.0026	CcSEcCtD
Pilocarpine—Hepatitis—Temozolomide—melanoma	0.000973	0.00258	CcSEcCtD
Pilocarpine—Asthenia—Vemurafenib—melanoma	0.00097	0.00258	CcSEcCtD
Pilocarpine—Visual impairment—Carmustine—melanoma	0.00097	0.00258	CcSEcCtD
Pilocarpine—Hypoaesthesia—Temozolomide—melanoma	0.000968	0.00257	CcSEcCtD
Pilocarpine—Pharyngitis—Temozolomide—melanoma	0.000965	0.00257	CcSEcCtD
Pilocarpine—Chills—Dactinomycin—melanoma	0.000965	0.00256	CcSEcCtD
Pilocarpine—Oedema peripheral—Temozolomide—melanoma	0.000958	0.00255	CcSEcCtD
Pilocarpine—Pruritus—Vemurafenib—melanoma	0.000957	0.00254	CcSEcCtD
Pilocarpine—Alopecia—Dactinomycin—melanoma	0.00095	0.00253	CcSEcCtD
Pilocarpine—Eye disorder—Carmustine—melanoma	0.000941	0.0025	CcSEcCtD
Pilocarpine—Visual impairment—Temozolomide—melanoma	0.000937	0.00249	CcSEcCtD
Pilocarpine—Flushing—Carmustine—melanoma	0.000934	0.00248	CcSEcCtD
Pilocarpine—Diarrhoea—Vemurafenib—melanoma	0.000925	0.00246	CcSEcCtD
Pilocarpine—Migraine—Docetaxel—melanoma	0.00092	0.00245	CcSEcCtD
Pilocarpine—Eye disorder—Temozolomide—melanoma	0.000909	0.00242	CcSEcCtD
Pilocarpine—Tinnitus—Temozolomide—melanoma	0.000907	0.00241	CcSEcCtD
Pilocarpine—Flushing—Temozolomide—melanoma	0.000903	0.0024	CcSEcCtD
Pilocarpine—Arrhythmia—Carmustine—melanoma	0.000899	0.00239	CcSEcCtD
Pilocarpine—Leukopenia—Bleomycin—melanoma	0.000899	0.00239	CcSEcCtD
Pilocarpine—Dizziness—Vemurafenib—melanoma	0.000894	0.00238	CcSEcCtD
Pilocarpine—Alopecia—Carmustine—melanoma	0.000889	0.00236	CcSEcCtD
Pilocarpine—Cough—Bleomycin—melanoma	0.000876	0.00233	CcSEcCtD
Pilocarpine—Chills—Temozolomide—melanoma	0.000873	0.00232	CcSEcCtD
Pilocarpine—Liver function test abnormal—Docetaxel—melanoma	0.000863	0.00229	CcSEcCtD
Pilocarpine—Vomiting—Vemurafenib—melanoma	0.00086	0.00228	CcSEcCtD
Pilocarpine—Alopecia—Temozolomide—melanoma	0.00086	0.00228	CcSEcCtD
Pilocarpine—Dry skin—Docetaxel—melanoma	0.000857	0.00228	CcSEcCtD
Pilocarpine—Chest pain—Bleomycin—melanoma	0.000855	0.00227	CcSEcCtD
Pilocarpine—Myalgia—Bleomycin—melanoma	0.000855	0.00227	CcSEcCtD
Pilocarpine—Rash—Vemurafenib—melanoma	0.000853	0.00227	CcSEcCtD
Pilocarpine—Dermatitis—Vemurafenib—melanoma	0.000852	0.00226	CcSEcCtD
Pilocarpine—Back pain—Carmustine—melanoma	0.000848	0.00225	CcSEcCtD
Pilocarpine—Headache—Vemurafenib—melanoma	0.000847	0.00225	CcSEcCtD
Pilocarpine—Discomfort—Bleomycin—melanoma	0.000844	0.00224	CcSEcCtD
Pilocarpine—Leukopenia—Dactinomycin—melanoma	0.000838	0.00223	CcSEcCtD
Pilocarpine—Dysgeusia—Temozolomide—melanoma	0.000829	0.0022	CcSEcCtD
Pilocarpine—Confusional state—Bleomycin—melanoma	0.000826	0.0022	CcSEcCtD
Pilocarpine—Vision blurred—Carmustine—melanoma	0.000826	0.00219	CcSEcCtD
Pilocarpine—Tremor—Carmustine—melanoma	0.000821	0.00218	CcSEcCtD
Pilocarpine—Oedema—Bleomycin—melanoma	0.000819	0.00218	CcSEcCtD
Pilocarpine—Back pain—Temozolomide—melanoma	0.000819	0.00218	CcSEcCtD
Pilocarpine—Infection—Bleomycin—melanoma	0.000814	0.00216	CcSEcCtD
Pilocarpine—Dysphagia—Docetaxel—melanoma	0.000808	0.00215	CcSEcCtD
Pilocarpine—Agitation—Carmustine—melanoma	0.000805	0.00214	CcSEcCtD
Pilocarpine—Nausea—Vemurafenib—melanoma	0.000803	0.00213	CcSEcCtD
Pilocarpine—Thrombocytopenia—Bleomycin—melanoma	0.000802	0.00213	CcSEcCtD
Pilocarpine—Vision blurred—Temozolomide—melanoma	0.000798	0.00212	CcSEcCtD
Pilocarpine—Myalgia—Dactinomycin—melanoma	0.000797	0.00212	CcSEcCtD
Pilocarpine—Bronchospasm—Docetaxel—melanoma	0.000795	0.00211	CcSEcCtD
Pilocarpine—Tremor—Temozolomide—melanoma	0.000793	0.00211	CcSEcCtD
Pilocarpine—Discomfort—Dactinomycin—melanoma	0.000787	0.00209	CcSEcCtD
Pilocarpine—Angina pectoris—Docetaxel—melanoma	0.000787	0.00209	CcSEcCtD
Pilocarpine—Leukopenia—Carmustine—melanoma	0.000784	0.00208	CcSEcCtD
Pilocarpine—Anorexia—Bleomycin—melanoma	0.000781	0.00208	CcSEcCtD
Pilocarpine—Agitation—Temozolomide—melanoma	0.000778	0.00207	CcSEcCtD
Pilocarpine—Hypotension—Bleomycin—melanoma	0.000766	0.00203	CcSEcCtD
Pilocarpine—Oedema—Dactinomycin—melanoma	0.000764	0.00203	CcSEcCtD
Pilocarpine—Infection—Dactinomycin—melanoma	0.000759	0.00202	CcSEcCtD
Pilocarpine—Leukopenia—Temozolomide—melanoma	0.000758	0.00201	CcSEcCtD
Pilocarpine—Hypertension—Carmustine—melanoma	0.000757	0.00201	CcSEcCtD
Pilocarpine—Palpitations—Temozolomide—melanoma	0.000748	0.00199	CcSEcCtD
Pilocarpine—Thrombocytopenia—Dactinomycin—melanoma	0.000748	0.00199	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000746	0.00198	CcSEcCtD
Pilocarpine—Chest pain—Carmustine—melanoma	0.000746	0.00198	CcSEcCtD
Pilocarpine—Myalgia—Carmustine—melanoma	0.000746	0.00198	CcSEcCtD
Pilocarpine—Anxiety—Carmustine—melanoma	0.000743	0.00198	CcSEcCtD
Pilocarpine—Cough—Temozolomide—melanoma	0.000739	0.00196	CcSEcCtD
Pilocarpine—Paraesthesia—Bleomycin—melanoma	0.000736	0.00195	CcSEcCtD
Pilocarpine—Hypertension—Temozolomide—melanoma	0.000731	0.00194	CcSEcCtD
Pilocarpine—Dyspnoea—Bleomycin—melanoma	0.00073	0.00194	CcSEcCtD
Pilocarpine—Anorexia—Dactinomycin—melanoma	0.000728	0.00194	CcSEcCtD
Pilocarpine—Pneumonia—Docetaxel—melanoma	0.000725	0.00193	CcSEcCtD
Pilocarpine—Confusional state—Carmustine—melanoma	0.000721	0.00192	CcSEcCtD
Pilocarpine—Myalgia—Temozolomide—melanoma	0.000721	0.00192	CcSEcCtD
Pilocarpine—Arthralgia—Temozolomide—melanoma	0.000721	0.00192	CcSEcCtD
Pilocarpine—Anxiety—Temozolomide—melanoma	0.000718	0.00191	CcSEcCtD
Pilocarpine—Oedema—Carmustine—melanoma	0.000715	0.0019	CcSEcCtD
Pilocarpine—Discomfort—Temozolomide—melanoma	0.000712	0.00189	CcSEcCtD
Pilocarpine—Decreased appetite—Bleomycin—melanoma	0.000712	0.00189	CcSEcCtD
Pilocarpine—Infection—Carmustine—melanoma	0.00071	0.00189	CcSEcCtD
Pilocarpine—Acute coronary syndrome—Docetaxel—melanoma	0.00071	0.00189	CcSEcCtD
Pilocarpine—Myocardial infarction—Docetaxel—melanoma	0.000706	0.00188	CcSEcCtD
Pilocarpine—Stomatitis—Docetaxel—melanoma	0.000702	0.00187	CcSEcCtD
Pilocarpine—Pain—Bleomycin—melanoma	0.000701	0.00186	CcSEcCtD
Pilocarpine—Conjunctivitis—Docetaxel—melanoma	0.0007	0.00186	CcSEcCtD
Pilocarpine—Thrombocytopenia—Carmustine—melanoma	0.0007	0.00186	CcSEcCtD
Pilocarpine—Tachycardia—Carmustine—melanoma	0.000698	0.00185	CcSEcCtD
Pilocarpine—Confusional state—Temozolomide—melanoma	0.000697	0.00185	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000696	0.00185	CcSEcCtD
Pilocarpine—Oedema—Temozolomide—melanoma	0.000691	0.00184	CcSEcCtD
Pilocarpine—Infection—Temozolomide—melanoma	0.000687	0.00182	CcSEcCtD
Pilocarpine—Anorexia—Carmustine—melanoma	0.000682	0.00181	CcSEcCtD
Pilocarpine—Epistaxis—Docetaxel—melanoma	0.00068	0.00181	CcSEcCtD
Pilocarpine—Thrombocytopenia—Temozolomide—melanoma	0.000677	0.0018	CcSEcCtD
Pilocarpine—Feeling abnormal—Bleomycin—melanoma	0.000675	0.00179	CcSEcCtD
Pilocarpine—Hypotension—Carmustine—melanoma	0.000668	0.00178	CcSEcCtD
Pilocarpine—Hyperhidrosis—Temozolomide—melanoma	0.000668	0.00178	CcSEcCtD
Pilocarpine—Decreased appetite—Dactinomycin—melanoma	0.000664	0.00177	CcSEcCtD
Pilocarpine—Anorexia—Temozolomide—melanoma	0.000659	0.00175	CcSEcCtD
Pilocarpine—Pain—Dactinomycin—melanoma	0.000653	0.00174	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Carmustine—melanoma	0.000652	0.00173	CcSEcCtD
Pilocarpine—Rhinitis—Docetaxel—melanoma	0.000649	0.00172	CcSEcCtD
Pilocarpine—Body temperature increased—Bleomycin—melanoma	0.000648	0.00172	CcSEcCtD
Pilocarpine—Hepatitis—Docetaxel—melanoma	0.000647	0.00172	CcSEcCtD
Pilocarpine—Insomnia—Carmustine—melanoma	0.000647	0.00172	CcSEcCtD
Pilocarpine—Hypoaesthesia—Docetaxel—melanoma	0.000644	0.00171	CcSEcCtD
Pilocarpine—Paraesthesia—Carmustine—melanoma	0.000642	0.00171	CcSEcCtD
Pilocarpine—Pharyngitis—Docetaxel—melanoma	0.000642	0.00171	CcSEcCtD
Pilocarpine—Dyspnoea—Carmustine—melanoma	0.000638	0.00169	CcSEcCtD
Pilocarpine—Oedema peripheral—Docetaxel—melanoma	0.000637	0.00169	CcSEcCtD
Pilocarpine—Somnolence—Carmustine—melanoma	0.000636	0.00169	CcSEcCtD
Pilocarpine—Feeling abnormal—Dactinomycin—melanoma	0.00063	0.00167	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Temozolomide—melanoma	0.00063	0.00167	CcSEcCtD
Pilocarpine—Insomnia—Temozolomide—melanoma	0.000625	0.00166	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Dactinomycin—melanoma	0.000625	0.00166	CcSEcCtD
Pilocarpine—Visual impairment—Docetaxel—melanoma	0.000623	0.00166	CcSEcCtD
Pilocarpine—Decreased appetite—Carmustine—melanoma	0.000622	0.00165	CcSEcCtD
Pilocarpine—Paraesthesia—Temozolomide—melanoma	0.000621	0.00165	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Carmustine—melanoma	0.000617	0.00164	CcSEcCtD
Pilocarpine—Dyspnoea—Temozolomide—melanoma	0.000616	0.00164	CcSEcCtD
Pilocarpine—Somnolence—Temozolomide—melanoma	0.000614	0.00163	CcSEcCtD
Pilocarpine—Pain—Carmustine—melanoma	0.000612	0.00163	CcSEcCtD
Pilocarpine—Constipation—Carmustine—melanoma	0.000612	0.00163	CcSEcCtD
Pilocarpine—Dyspepsia—Temozolomide—melanoma	0.000608	0.00162	CcSEcCtD
Pilocarpine—Eye disorder—Docetaxel—melanoma	0.000605	0.00161	CcSEcCtD
Pilocarpine—Body temperature increased—Dactinomycin—melanoma	0.000604	0.00161	CcSEcCtD
Pilocarpine—Abdominal pain—Dactinomycin—melanoma	0.000604	0.00161	CcSEcCtD
Pilocarpine—Hypersensitivity—Bleomycin—melanoma	0.000604	0.0016	CcSEcCtD
Pilocarpine—Decreased appetite—Temozolomide—melanoma	0.000601	0.0016	CcSEcCtD
Pilocarpine—Flushing—Docetaxel—melanoma	0.0006	0.0016	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Temozolomide—melanoma	0.000597	0.00159	CcSEcCtD
Pilocarpine—Constipation—Temozolomide—melanoma	0.000591	0.00157	CcSEcCtD
Pilocarpine—Pain—Temozolomide—melanoma	0.000591	0.00157	CcSEcCtD
Pilocarpine—Feeling abnormal—Carmustine—melanoma	0.000589	0.00157	CcSEcCtD
Pilocarpine—Asthenia—Bleomycin—melanoma	0.000588	0.00156	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Carmustine—melanoma	0.000585	0.00155	CcSEcCtD
Pilocarpine—Chills—Docetaxel—melanoma	0.00058	0.00154	CcSEcCtD
Pilocarpine—Pruritus—Bleomycin—melanoma	0.00058	0.00154	CcSEcCtD
Pilocarpine—Arrhythmia—Docetaxel—melanoma	0.000578	0.00154	CcSEcCtD
Pilocarpine—Alopecia—Docetaxel—melanoma	0.000572	0.00152	CcSEcCtD
Pilocarpine—Feeling abnormal—Temozolomide—melanoma	0.000569	0.00151	CcSEcCtD
Pilocarpine—Abdominal pain—Carmustine—melanoma	0.000565	0.0015	CcSEcCtD
Pilocarpine—Body temperature increased—Carmustine—melanoma	0.000565	0.0015	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Temozolomide—melanoma	0.000565	0.0015	CcSEcCtD
Pilocarpine—Hypersensitivity—Dactinomycin—melanoma	0.000563	0.0015	CcSEcCtD
Pilocarpine—Dysgeusia—Docetaxel—melanoma	0.000551	0.00147	CcSEcCtD
Pilocarpine—Asthenia—Dactinomycin—melanoma	0.000548	0.00146	CcSEcCtD
Pilocarpine—Abdominal pain—Temozolomide—melanoma	0.000546	0.00145	CcSEcCtD
Pilocarpine—Body temperature increased—Temozolomide—melanoma	0.000546	0.00145	CcSEcCtD
Pilocarpine—Back pain—Docetaxel—melanoma	0.000545	0.00145	CcSEcCtD
Pilocarpine—Muscle spasms—Docetaxel—melanoma	0.000541	0.00144	CcSEcCtD
Pilocarpine—Hypersensitivity—Carmustine—melanoma	0.000527	0.0014	CcSEcCtD
Pilocarpine—Diarrhoea—Dactinomycin—melanoma	0.000523	0.00139	CcSEcCtD
Pilocarpine—Vomiting—Bleomycin—melanoma	0.000521	0.00138	CcSEcCtD
Pilocarpine—Rash—Bleomycin—melanoma	0.000517	0.00137	CcSEcCtD
Pilocarpine—Dermatitis—Bleomycin—melanoma	0.000516	0.00137	CcSEcCtD
Pilocarpine—Asthenia—Carmustine—melanoma	0.000513	0.00136	CcSEcCtD
Pilocarpine—Hypersensitivity—Temozolomide—melanoma	0.000509	0.00135	CcSEcCtD
Pilocarpine—Syncope—Docetaxel—melanoma	0.000505	0.00134	CcSEcCtD
Pilocarpine—Leukopenia—Docetaxel—melanoma	0.000504	0.00134	CcSEcCtD
Pilocarpine—Palpitations—Docetaxel—melanoma	0.000498	0.00132	CcSEcCtD
Pilocarpine—Asthenia—Temozolomide—melanoma	0.000496	0.00132	CcSEcCtD
Pilocarpine—Loss of consciousness—Docetaxel—melanoma	0.000495	0.00132	CcSEcCtD
Pilocarpine—Cough—Docetaxel—melanoma	0.000491	0.00131	CcSEcCtD
Pilocarpine—Diarrhoea—Carmustine—melanoma	0.000489	0.0013	CcSEcCtD
Pilocarpine—Pruritus—Temozolomide—melanoma	0.000489	0.0013	CcSEcCtD
Pilocarpine—Nausea—Bleomycin—melanoma	0.000487	0.00129	CcSEcCtD
Pilocarpine—Hypertension—Docetaxel—melanoma	0.000486	0.00129	CcSEcCtD
Pilocarpine—Vomiting—Dactinomycin—melanoma	0.000486	0.00129	CcSEcCtD
Pilocarpine—Rash—Dactinomycin—melanoma	0.000482	0.00128	CcSEcCtD
Pilocarpine—Chest pain—Docetaxel—melanoma	0.000479	0.00127	CcSEcCtD
Pilocarpine—Arthralgia—Docetaxel—melanoma	0.000479	0.00127	CcSEcCtD
Pilocarpine—Myalgia—Docetaxel—melanoma	0.000479	0.00127	CcSEcCtD
Pilocarpine—Dizziness—Carmustine—melanoma	0.000473	0.00126	CcSEcCtD
Pilocarpine—Diarrhoea—Temozolomide—melanoma	0.000473	0.00126	CcSEcCtD
Pilocarpine—Confusional state—Docetaxel—melanoma	0.000463	0.00123	CcSEcCtD
Pilocarpine—Oedema—Docetaxel—melanoma	0.00046	0.00122	CcSEcCtD
Pilocarpine—Dizziness—Temozolomide—melanoma	0.000457	0.00121	CcSEcCtD
Pilocarpine—Infection—Docetaxel—melanoma	0.000457	0.00121	CcSEcCtD
Pilocarpine—Vomiting—Carmustine—melanoma	0.000455	0.00121	CcSEcCtD
Pilocarpine—Nausea—Dactinomycin—melanoma	0.000454	0.00121	CcSEcCtD
Pilocarpine—Shock—Docetaxel—melanoma	0.000452	0.0012	CcSEcCtD
Pilocarpine—Rash—Carmustine—melanoma	0.000451	0.0012	CcSEcCtD
Pilocarpine—Dermatitis—Carmustine—melanoma	0.00045	0.0012	CcSEcCtD
Pilocarpine—Thrombocytopenia—Docetaxel—melanoma	0.00045	0.0012	CcSEcCtD
Pilocarpine—Tachycardia—Docetaxel—melanoma	0.000449	0.00119	CcSEcCtD
Pilocarpine—Headache—Carmustine—melanoma	0.000448	0.00119	CcSEcCtD
Pilocarpine—Vomiting—Temozolomide—melanoma	0.000439	0.00117	CcSEcCtD
Pilocarpine—Anorexia—Docetaxel—melanoma	0.000438	0.00116	CcSEcCtD
Pilocarpine—Rash—Temozolomide—melanoma	0.000436	0.00116	CcSEcCtD
Pilocarpine—Dermatitis—Temozolomide—melanoma	0.000435	0.00116	CcSEcCtD
Pilocarpine—Headache—Temozolomide—melanoma	0.000433	0.00115	CcSEcCtD
Pilocarpine—Hypotension—Docetaxel—melanoma	0.000429	0.00114	CcSEcCtD
Pilocarpine—Nausea—Carmustine—melanoma	0.000425	0.00113	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000419	0.00111	CcSEcCtD
Pilocarpine—Insomnia—Docetaxel—melanoma	0.000416	0.0011	CcSEcCtD
Pilocarpine—Paraesthesia—Docetaxel—melanoma	0.000413	0.0011	CcSEcCtD
Pilocarpine—Nausea—Temozolomide—melanoma	0.00041	0.00109	CcSEcCtD
Pilocarpine—Dyspnoea—Docetaxel—melanoma	0.00041	0.00109	CcSEcCtD
Pilocarpine—Somnolence—Docetaxel—melanoma	0.000409	0.00109	CcSEcCtD
Pilocarpine—Dyspepsia—Docetaxel—melanoma	0.000405	0.00108	CcSEcCtD
Pilocarpine—Decreased appetite—Docetaxel—melanoma	0.0004	0.00106	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Docetaxel—melanoma	0.000397	0.00105	CcSEcCtD
Pilocarpine—Pain—Docetaxel—melanoma	0.000393	0.00104	CcSEcCtD
Pilocarpine—Constipation—Docetaxel—melanoma	0.000393	0.00104	CcSEcCtD
Pilocarpine—Feeling abnormal—Docetaxel—melanoma	0.000379	0.00101	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Docetaxel—melanoma	0.000376	0.000999	CcSEcCtD
Pilocarpine—Body temperature increased—Docetaxel—melanoma	0.000363	0.000965	CcSEcCtD
Pilocarpine—Abdominal pain—Docetaxel—melanoma	0.000363	0.000965	CcSEcCtD
Pilocarpine—Hypersensitivity—Docetaxel—melanoma	0.000339	0.0009	CcSEcCtD
Pilocarpine—Asthenia—Docetaxel—melanoma	0.00033	0.000876	CcSEcCtD
Pilocarpine—Pruritus—Docetaxel—melanoma	0.000325	0.000864	CcSEcCtD
Pilocarpine—Diarrhoea—Docetaxel—melanoma	0.000314	0.000836	CcSEcCtD
Pilocarpine—Dizziness—Docetaxel—melanoma	0.000304	0.000808	CcSEcCtD
Pilocarpine—Vomiting—Docetaxel—melanoma	0.000292	0.000777	CcSEcCtD
Pilocarpine—Rash—Docetaxel—melanoma	0.00029	0.00077	CcSEcCtD
Pilocarpine—Dermatitis—Docetaxel—melanoma	0.00029	0.000769	CcSEcCtD
Pilocarpine—Headache—Docetaxel—melanoma	0.000288	0.000765	CcSEcCtD
Pilocarpine—Nausea—Docetaxel—melanoma	0.000273	0.000725	CcSEcCtD
Pilocarpine—CHRM1—Signaling Pathways—EDN1—melanoma	2.17e-05	0.000194	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—EDN1—melanoma	2.17e-05	0.000193	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CD86—melanoma	2.16e-05	0.000193	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—CXCL8—melanoma	2.16e-05	0.000193	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—EDN1—melanoma	2.15e-05	0.000192	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CSF2—melanoma	2.13e-05	0.00019	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—FGF1—melanoma	2.13e-05	0.00019	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—FGF1—melanoma	2.12e-05	0.000189	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CSF2—melanoma	2.12e-05	0.000189	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CSF2—melanoma	2.1e-05	0.000187	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—FGF1—melanoma	2.1e-05	0.000187	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—IL2—melanoma	2.09e-05	0.000187	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—IL2—melanoma	2.09e-05	0.000186	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—E2F1—melanoma	2.08e-05	0.000186	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—E2F1—melanoma	2.07e-05	0.000185	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—PIK3CB—melanoma	2.07e-05	0.000185	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—IL2—melanoma	2.07e-05	0.000184	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—PIK3CB—melanoma	2.06e-05	0.000184	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PDGFRA—melanoma	2.06e-05	0.000184	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—E2F1—melanoma	2.05e-05	0.000183	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PDGFRA—melanoma	2.05e-05	0.000183	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PRKCA—melanoma	2.05e-05	0.000183	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—PIK3CB—melanoma	2.04e-05	0.000182	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PRKCA—melanoma	2.04e-05	0.000182	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—ITGB3—melanoma	2.04e-05	0.000182	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PDGFRA—melanoma	2.03e-05	0.000181	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PRKCA—melanoma	2.03e-05	0.000181	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—ITGB3—melanoma	2.03e-05	0.000181	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—ERCC2—melanoma	2.03e-05	0.000181	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PIK3CG—melanoma	2.03e-05	0.000181	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—ITGB3—melanoma	2.01e-05	0.000179	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PRKCA—melanoma	2.01e-05	0.000179	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—SPP1—melanoma	2e-05	0.000178	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MAP2K2—melanoma	1.99e-05	0.000178	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—SPP1—melanoma	1.99e-05	0.000178	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—CXCL8—melanoma	1.99e-05	0.000178	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MAP2K2—melanoma	1.99e-05	0.000177	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—CXCL8—melanoma	1.98e-05	0.000177	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—SPP1—melanoma	1.97e-05	0.000176	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MAP2K2—melanoma	1.97e-05	0.000175	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PLA2G6—melanoma	1.96e-05	0.000175	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—CXCL8—melanoma	1.96e-05	0.000175	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PPARG—melanoma	1.96e-05	0.000175	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PIK3CG—melanoma	1.9e-05	0.00017	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—IL2—melanoma	1.9e-05	0.00017	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—IL2—melanoma	1.9e-05	0.000169	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TERT—melanoma	1.89e-05	0.000169	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—RAC1—melanoma	1.89e-05	0.000169	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TERT—melanoma	1.89e-05	0.000169	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—RAC1—melanoma	1.88e-05	0.000168	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—IL2—melanoma	1.88e-05	0.000167	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TERT—melanoma	1.87e-05	0.000167	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—RAC1—melanoma	1.86e-05	0.000166	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PPARG—melanoma	1.84e-05	0.000164	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—HIF1A—melanoma	1.81e-05	0.000162	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—HIF1A—melanoma	1.81e-05	0.000161	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—HIF1A—melanoma	1.79e-05	0.00016	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PIK3CD—melanoma	1.78e-05	0.000159	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—VCAN—melanoma	1.76e-05	0.000157	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—ALB—melanoma	1.76e-05	0.000157	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—KDR—melanoma	1.73e-05	0.000155	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—KDR—melanoma	1.73e-05	0.000154	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—KDR—melanoma	1.71e-05	0.000153	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PIK3CD—melanoma	1.67e-05	0.000149	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—FN1—melanoma	1.67e-05	0.000149	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—FN1—melanoma	1.66e-05	0.000148	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—ALB—melanoma	1.65e-05	0.000147	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—FN1—melanoma	1.65e-05	0.000147	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—NOTCH1—melanoma	1.63e-05	0.000146	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—NOTCH1—melanoma	1.63e-05	0.000145	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—NOTCH1—melanoma	1.61e-05	0.000144	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PIK3CG—melanoma	1.6e-05	0.000143	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CD80—melanoma	1.6e-05	0.000143	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PIK3CG—melanoma	1.6e-05	0.000142	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—KIT—melanoma	1.6e-05	0.000142	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—APC—melanoma	1.6e-05	0.000142	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—NRAS—melanoma	1.6e-05	0.000142	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CD80—melanoma	1.59e-05	0.000142	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PIK3CG—melanoma	1.59e-05	0.000142	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—APC—melanoma	1.59e-05	0.000142	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—KIT—melanoma	1.59e-05	0.000142	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—NRAS—melanoma	1.59e-05	0.000142	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CD80—melanoma	1.58e-05	0.000141	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—EGF—melanoma	1.58e-05	0.000141	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—KIT—melanoma	1.58e-05	0.000141	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—APC—melanoma	1.58e-05	0.000141	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PIK3CG—melanoma	1.58e-05	0.000141	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—NRAS—melanoma	1.58e-05	0.000141	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—EGF—melanoma	1.57e-05	0.00014	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—EGF—melanoma	1.56e-05	0.000139	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PIK3CB—melanoma	1.55e-05	0.000139	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PPARG—melanoma	1.55e-05	0.000138	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PTGS2—melanoma	1.54e-05	0.000137	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—MAPK3—melanoma	1.53e-05	0.000136	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—MAPK3—melanoma	1.52e-05	0.000136	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—MAPK3—melanoma	1.51e-05	0.000135	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—BRAF—melanoma	1.5e-05	0.000134	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—BRAF—melanoma	1.5e-05	0.000133	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP17A1—melanoma	1.49e-05	0.000133	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—BRAF—melanoma	1.48e-05	0.000132	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IGF1—melanoma	1.46e-05	0.00013	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PIK3CB—melanoma	1.46e-05	0.00013	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IGF1—melanoma	1.46e-05	0.00013	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—MAPK1—melanoma	1.45e-05	0.00013	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—EGFR—melanoma	1.45e-05	0.00013	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—MAPK1—melanoma	1.45e-05	0.000129	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—EGFR—melanoma	1.45e-05	0.000129	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PTGS2—melanoma	1.44e-05	0.000129	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IGF1—melanoma	1.44e-05	0.000129	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—MAPK1—melanoma	1.44e-05	0.000128	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—EGFR—melanoma	1.44e-05	0.000128	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MAP2K1—melanoma	1.41e-05	0.000126	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PIK3CD—melanoma	1.41e-05	0.000126	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MAP2K1—melanoma	1.41e-05	0.000126	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GNA11—melanoma	1.41e-05	0.000125	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PIK3CD—melanoma	1.4e-05	0.000125	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PIK3CD—melanoma	1.4e-05	0.000125	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MAP2K1—melanoma	1.39e-05	0.000124	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—ALB—melanoma	1.39e-05	0.000124	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—PIK3CA—melanoma	1.39e-05	0.000124	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—PIK3CA—melanoma	1.39e-05	0.000124	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PIK3CD—melanoma	1.38e-05	0.000124	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—FASN—melanoma	1.38e-05	0.000123	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—KRAS—melanoma	1.37e-05	0.000123	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—PIK3CA—melanoma	1.37e-05	0.000122	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—KRAS—melanoma	1.37e-05	0.000122	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—KRAS—melanoma	1.36e-05	0.000121	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—SLC5A5—melanoma	1.35e-05	0.000121	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—FGF2—melanoma	1.34e-05	0.00012	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PTEN—melanoma	1.34e-05	0.00012	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—FGF2—melanoma	1.34e-05	0.00012	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—FGF2—melanoma	1.33e-05	0.000118	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GNAQ—melanoma	1.31e-05	0.000117	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CD44—melanoma	1.31e-05	0.000117	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—PIK3CA—melanoma	1.26e-05	0.000113	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PTEN—melanoma	1.26e-05	0.000112	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—PIK3CA—melanoma	1.26e-05	0.000112	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MDM2—melanoma	1.26e-05	0.000112	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP1B1—melanoma	1.25e-05	0.000112	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MDM2—melanoma	1.25e-05	0.000112	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—PIK3CA—melanoma	1.25e-05	0.000111	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MDM2—melanoma	1.24e-05	0.000111	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—ERBB2—melanoma	1.24e-05	0.000111	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—ERBB2—melanoma	1.24e-05	0.00011	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PIK3CB—melanoma	1.23e-05	0.00011	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—ERBB2—melanoma	1.22e-05	0.000109	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PIK3CB—melanoma	1.22e-05	0.000109	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PIK3CB—melanoma	1.22e-05	0.000109	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PTGS2—melanoma	1.22e-05	0.000109	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PIK3CB—melanoma	1.21e-05	0.000108	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CXCL8—melanoma	1.18e-05	0.000105	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CXCL8—melanoma	1.17e-05	0.000105	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—HRAS—melanoma	1.17e-05	0.000104	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—HRAS—melanoma	1.16e-05	0.000104	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CXCL8—melanoma	1.16e-05	0.000104	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—HRAS—melanoma	1.15e-05	0.000103	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CDKN1B—melanoma	1.15e-05	0.000102	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CDKN1B—melanoma	1.14e-05	0.000102	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—AKT1—melanoma	1.14e-05	0.000101	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CDKN1B—melanoma	1.13e-05	0.000101	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—AKT1—melanoma	1.13e-05	0.000101	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CASP3—melanoma	1.12e-05	0.0001	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IL2—melanoma	1.12e-05	0.0001	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CASP3—melanoma	1.12e-05	0.0001	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—AKT1—melanoma	1.12e-05	0.0001	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IL2—melanoma	1.12e-05	9.99e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—IL6—melanoma	1.12e-05	9.97e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—IL6—melanoma	1.11e-05	9.94e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CASP3—melanoma	1.11e-05	9.91e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IL2—melanoma	1.11e-05	9.89e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—IL6—melanoma	1.1e-05	9.84e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CCND1—melanoma	1.09e-05	9.77e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CCND1—melanoma	1.09e-05	9.74e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CTNNB1—melanoma	1.08e-05	9.68e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CCND1—melanoma	1.08e-05	9.64e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CTNNB1—melanoma	1.08e-05	9.64e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CTNNB1—melanoma	1.07e-05	9.55e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MMP9—melanoma	1.06e-05	9.49e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PTEN—melanoma	1.06e-05	9.47e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MMP9—melanoma	1.06e-05	9.46e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CDKN1A—melanoma	1.06e-05	9.45e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PTEN—melanoma	1.06e-05	9.43e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CDKN1A—melanoma	1.06e-05	9.42e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PTEN—melanoma	1.05e-05	9.4e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—NFKB1—melanoma	1.05e-05	9.39e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MMP9—melanoma	1.05e-05	9.36e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—NFKB1—melanoma	1.05e-05	9.36e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CDKN1A—melanoma	1.05e-05	9.33e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PTEN—melanoma	1.04e-05	9.31e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—NFKB1—melanoma	1.04e-05	9.26e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ABCB1—melanoma	1.03e-05	9.21e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—AKT1—melanoma	1.03e-05	9.2e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—AKT1—melanoma	1.03e-05	9.17e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—AKT1—melanoma	1.02e-05	9.08e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—VEGFA—melanoma	9.54e-06	8.52e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—VEGFA—melanoma	9.51e-06	8.49e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PRKCA—melanoma	9.5e-06	8.47e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PIK3CA—melanoma	9.48e-06	8.46e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—STAT3—melanoma	9.45e-06	8.43e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—NRAS—melanoma	9.43e-06	8.41e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—VEGFA—melanoma	9.42e-06	8.41e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—STAT3—melanoma	9.42e-06	8.41e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ERCC2—melanoma	9.42e-06	8.4e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—NRAS—melanoma	9.4e-06	8.39e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—STAT3—melanoma	9.33e-06	8.33e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—NRAS—melanoma	9.31e-06	8.31e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MAPK3—melanoma	9.03e-06	8.06e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MAPK3—melanoma	9e-06	8.03e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MAPK3—melanoma	8.91e-06	7.95e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PIK3CA—melanoma	8.89e-06	7.93e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MYC—melanoma	8.78e-06	7.84e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MYC—melanoma	8.75e-06	7.81e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MYC—melanoma	8.67e-06	7.74e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MAPK1—melanoma	8.59e-06	7.67e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—EGFR—melanoma	8.59e-06	7.67e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MAPK1—melanoma	8.56e-06	7.64e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—EGFR—melanoma	8.56e-06	7.64e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MAPK1—melanoma	8.48e-06	7.57e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—EGFR—melanoma	8.48e-06	7.57e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—KRAS—melanoma	8.11e-06	7.24e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—KRAS—melanoma	8.09e-06	7.22e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—KRAS—melanoma	8.01e-06	7.15e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—AKT1—melanoma	7.74e-06	6.91e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PIK3CA—melanoma	7.49e-06	6.68e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PIK3CA—melanoma	7.46e-06	6.65e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PIK3CG—melanoma	7.44e-06	6.64e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PIK3CA—melanoma	7.43e-06	6.63e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PIK3CA—melanoma	7.36e-06	6.57e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—AKT1—melanoma	7.26e-06	6.48e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TP53—melanoma	7.21e-06	6.44e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TP53—melanoma	7.19e-06	6.42e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PPARG—melanoma	7.18e-06	6.41e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TP53—melanoma	7.12e-06	6.35e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—HRAS—melanoma	6.9e-06	6.16e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—HRAS—melanoma	6.88e-06	6.14e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—HRAS—melanoma	6.81e-06	6.08e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IL6—melanoma	6.6e-06	5.89e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IL6—melanoma	6.58e-06	5.87e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PIK3CD—melanoma	6.54e-06	5.84e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IL6—melanoma	6.52e-06	5.82e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ALB—melanoma	6.45e-06	5.76e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—AKT1—melanoma	6.12e-06	5.46e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—AKT1—melanoma	6.09e-06	5.43e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—AKT1—melanoma	6.07e-06	5.42e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—AKT1—melanoma	6.01e-06	5.36e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PIK3CB—melanoma	5.7e-06	5.09e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PTGS2—melanoma	5.65e-06	5.04e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PTEN—melanoma	4.92e-06	4.39e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PIK3CA—melanoma	3.47e-06	3.1e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—AKT1—melanoma	2.84e-06	2.53e-05	CbGpPWpGaD
